JP2015142720A5 - - Google Patents

Download PDF

Info

Publication number
JP2015142720A5
JP2015142720A5 JP2014225283A JP2014225283A JP2015142720A5 JP 2015142720 A5 JP2015142720 A5 JP 2015142720A5 JP 2014225283 A JP2014225283 A JP 2014225283A JP 2014225283 A JP2014225283 A JP 2014225283A JP 2015142720 A5 JP2015142720 A5 JP 2015142720A5
Authority
JP
Japan
Prior art keywords
seq
self
hemostatic material
gel
material according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014225283A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015142720A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014225283A priority Critical patent/JP2015142720A/ja
Priority claimed from JP2014225283A external-priority patent/JP2015142720A/ja
Priority to PCT/JP2014/082653 priority patent/WO2015098515A1/ja
Publication of JP2015142720A publication Critical patent/JP2015142720A/ja
Publication of JP2015142720A5 publication Critical patent/JP2015142720A5/ja
Pending legal-status Critical Current

Links

JP2014225283A 2013-12-27 2014-11-05 止血材 Pending JP2015142720A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2014225283A JP2015142720A (ja) 2013-12-27 2014-11-05 止血材
PCT/JP2014/082653 WO2015098515A1 (ja) 2013-12-27 2014-12-10 止血材

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013271430 2013-12-27
JP2013271430 2013-12-27
JP2014225283A JP2015142720A (ja) 2013-12-27 2014-11-05 止血材

Publications (2)

Publication Number Publication Date
JP2015142720A JP2015142720A (ja) 2015-08-06
JP2015142720A5 true JP2015142720A5 (enExample) 2016-06-16

Family

ID=53478379

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014225283A Pending JP2015142720A (ja) 2013-12-27 2014-11-05 止血材

Country Status (2)

Country Link
JP (1) JP2015142720A (enExample)
WO (1) WO2015098515A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015288635B2 (en) * 2014-07-11 2018-07-26 Menicon Co., Ltd. Visibility-ensuring material, and device for discharging visibility-ensuring material
US11298397B2 (en) 2015-12-18 2022-04-12 3-D Matrix, Ltd. Hemostatic composition and hemostatic method using hemostatic composition
KR102647642B1 (ko) * 2021-05-04 2024-03-15 (주)케어젠 혈액 응고 활성을 갖는 펩타이드와 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9327010B2 (en) * 2005-04-25 2016-05-03 Massachusetts Institute Of Technology Compositions and methods for promoting hemostasis and other physiological activities
US8299032B2 (en) * 2005-06-27 2012-10-30 Menicon Co., Ltd. Self-assembling peptide and gel produced from the same
EP2345433B1 (en) * 2008-10-06 2017-03-01 3-D Matrix, Ltd. Tissue plug
JP6084352B2 (ja) * 2010-12-24 2017-02-22 国立大学法人 岡山大学 高強度ペプチドゲル

Similar Documents

Publication Publication Date Title
RU2016139369A (ru) Композиции самоорганизующихся пептидов
RU2019138024A (ru) ХЛОРИДНАЯ СОЛЬ ПЕПТИДА TAT-NR2B9c, КОМПОЗИЦИЯ НА ЕГО ОСНОВЕ И СПОСОБЫ ИХ ПОЛУЧЕНИЯ
RU2015119517A (ru) Новый способ лечения инфаркта миокарда с применением фрагмента hmgb1
WO2015028966A3 (en) Amino diacids containing peptide modifiers
NZ628446A (en) Fibronectin based scaffold domain proteins that bind to myostatin
JP2014518844A5 (enExample)
JP2011152140A5 (enExample)
JP2013520405A5 (enExample)
JP2015142720A5 (enExample)
MX2014015799A (es) Composiciones farmaceuticas que comprenden rifaximina y aminoacidos, metodo de preparacion y uso de las mismas.
RU2015123740A (ru) Способ индикации времени для мытья или индикации высвобождения антибактериального средства
EA201300830A1 (ru) Полутвердый пищевой концентрат в виде пасты или геля
AR103954A1 (es) Análogos de amilina
Sharma et al. Solvation behavior of some amino acids in aqueous solutions of non-steroidal anti-inflammatory drug sodium ibuprofen at different temperatures analysed by volumetric and acoustic methods
NZ743984A (en) Compositions comprising polyethylene glycol, alkali metal or alkaline earth metal sulphates and electrolytes for use as colon cleansing compositions
CL2017000773A1 (es) Proceso para la producción de granulados de sulfato de potasio y el granulado de sulfato de potasio obtenido a partir del mismo, así como también su uso.
CY1116168T1 (el) Συγκρυσταλλοι και αλατα αναστολεων toy ccr3
JP2014503607A5 (enExample)
JP2015524403A5 (enExample)
JP2017502045A5 (enExample)
EA201700258A3 (ru) Раствор для очищения толстой кишки, композиция для очищения толстой кишки (варианты), набор (варианты), композиция для смешивания с водой, способ очищения толстой кишки и его использование
JP2015520178A5 (enExample)
RU2016138577A (ru) Жидкая фармцевтическая композиция
EA033437B9 (ru) Fc-гамма-рецептор iib и его применение для лечения или предупреждения воспалительных и/или аутоиммунных заболеваний
RU2016140474A (ru) Шина